RETRACTION: Sodium-Glucose Co-Transporter-2 Inhibitor Empagliflozin Attenuates Sorafenib-Induced Myocardial Inflammation and Toxicity.

RETRACTION: C.-H. Liu, Y.-C. Ho, W.-C. Lee, C.-Y. Huang, Y.-K. Lee, C.-B. Hsieh, N.-C. Huang, C.-C. Wu, N. U. N. Nguyen, C.-C. Hsu, C.-H. Chen, Y.-C. Chen, W.-C. Huang, Y.-Y. Lu, C.-C. Fang, Y.-C. Chang, C.-L. Chang, M.-K. Tsai, Z.-H. Wen, C.-Z. Li,…

Preview only. Read the full abstract at the source